Subscribe
shutterstock_1857404794_michael_vi
Michael Vi / Shutterstock.com
2 February 2021GeneticsAlex Baldwin

Illumina wins PTAB appeal over Columbia DNA patents

Biotech company Illumina has won a dispute with Columbia University, after the Court of Appeals for the Federal Circuit backed an earlier ruling that the university’s DNA-sequencing patents were invalid.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
BGI counter sues Illumina for patent infringement
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
Federal Circuit affirms invalidation of two Illumina patents
1 February 2016   The US Court of Appeals for the Federal Circuit has knocked out two patents belonging to biotechnology company Illumina following a challenge by Intelligent Bio-Systems.


Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024

More on this story

Big Pharma
BGI counter sues Illumina for patent infringement
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
Federal Circuit affirms invalidation of two Illumina patents
1 February 2016   The US Court of Appeals for the Federal Circuit has knocked out two patents belonging to biotechnology company Illumina following a challenge by Intelligent Bio-Systems.

More on this story

Big Pharma
BGI counter sues Illumina for patent infringement
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
Federal Circuit affirms invalidation of two Illumina patents
1 February 2016   The US Court of Appeals for the Federal Circuit has knocked out two patents belonging to biotechnology company Illumina following a challenge by Intelligent Bio-Systems.

More features

Gilead scores win in fake HIV drug dispute
Polsinelli grows roster with ex-corporate counsel
‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird
Sandoz wins $137.2m payout for lost profits in generic launch
Sanofi signs global rights deal to develop rare cancer therapy
Unified Patent Court visualised: Cases, divisions, and classes in charts
WBD to merge with firm to create ‘powerhouse’ practice
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers